|
|
Volumn 5, Issue 11, 2006, Pages 881-882
|
|
The trouble with making combination drugs
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ABACAVIR;
ABACAVIR PLUS LAMIVUDINE;
ABACAVIR PLUS LAMIVUDINE PLUS ZIDOVUDINE;
ABT 335;
ACETYLSALICYLIC ACID;
AMLODIPINE PLUS ATORVASTATIN;
ATORVASTATIN;
ATRIPLA;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
DRUG;
EFAVIRENZ;
EMTRICITABINE;
EMTRICITABINE PLUS TENOFOVIR DISOPROXIL;
EZETIMIBE PLUS SIMVASTATIN;
FIBRIC ACID DERIVATIVE;
GENERIC DRUG;
HYDRALAZINE PLUS ISOSORBIDE DINITRATE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
HYPOCHOLESTEROLEMIC AGENT;
LAMIVUDINE;
LAMIVUDINE PLUS ZIDOVUDINE;
MK 0524A;
MK 524B;
NEVIRAPINE;
NICOTINIC ACID;
ROSUVASTATIN;
SIMVASTATIN;
TENOFOVIR;
UNCLASSIFIED DRUG;
UNINDEXED DRUG;
ZIDOVUDINE;
ARTICLE;
CARDIOVASCULAR DISEASE;
COMBINATION CHEMOTHERAPY;
DEVELOPING COUNTRY;
DRUG FORMULATION;
DRUG INDUSTRY;
DRUG MANUFACTURE;
DRUG SOLUBILITY;
EUROPE;
FUNDING;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LONG TERM CARE;
PATIENT COMPLIANCE;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
SECONDARY PREVENTION;
TABLET COMPRESSION;
TABLET FORMULATION;
UNITED STATES;
WESTERN HEMISPHERE;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTI-HIV AGENTS;
ASPIRIN;
CHEMISTRY, PHARMACEUTICAL;
DRUG COMBINATIONS;
DRUG INDUSTRY;
DRUG THERAPY;
HUMANS;
HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS;
PHARMACEUTICAL PREPARATIONS;
PLATELET AGGREGATION INHIBITORS;
|
|
EID: 33750546736
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd2188 Document Type: Article |
|
Times cited : (80)
|
|
References (0)
|